Laden…
Substance Comparison
PCP stands out with markedly stronger dissociation. PCP leans slightly higher in addiction risk.
Despite belonging to different classes, these substances share receptor activity at NMDA and DAT, which may produce overlapping effects.
PCP has significantly higher dissociation
PCP has somewhat higher addiction risk
| Oxiracetam | PCP | |
|---|---|---|
| Class | Racetam | Dissoziativa |
| Risk Level | — | high |
| Mechanisms | AMPA-Rezeptor-Modulation, Förderung der Acetylcholinfreisetzung | NMDA-Antagonist, DAT-Inhibitor, Sigma-Agonist |
| Receptors | AMPA, NMDA, AChE, 5-HT2A, DAT | NMDA, DAT, Sigma-1 |
| Effects | Verbesserte Konzentration und Fokus, Gesteigerte Gedächtnisleistung, Erhöhte mentale Klarheit, Verbesserte Lernfähigkeit, Neuroprotektive Wirkung | — |
| Evidence | unknown | — |
Oxiracetam wirkt als Modulator der AMPA- und NMDA-Rezeptoren, was zu einer Verbesserung der synaptischen Übertragung und kognitiven Funktionen führt.
Safer-use data available on substance page
No harm reduction data available
Evidence: unknown · Sources: 2
Evidence: not assessed · Sources: 2